SCHEMBL4386262

SCHEMBL4386262

CC1=CC=CNC1[C@H]1CCC[C@@H](c2ncccc2C)N1Cc1ccc(CO)cc1C#N

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 6/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2476959 0.87 CXCR4 (0.35) CXCR4
SCHEMBL2501820 0.86 CXCR4 (0.41) CXCR4
SCHEMBL15387266 0.84 CXCR4 (0.33) CXCR4
SCHEMBL11903970 0.77 GAA (0.40) CXCR4
SCHEMBL4239716 0.76 HDAC6 (0.37) CXCR4
SCHEMBL11904119 0.76 P2RX3 (0.30)
SCHEMBL11904802 0.75 CXCR4 (0.32) CXCR4
SCHEMBL8301709 0.74 CXCR4 (0.40) CXCR4
SCHEMBL2474527 0.72 CXCR4 (0.39) CXCR4
SCHEMBL8306813 0.72 CXCR4 (0.39) CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550484-B2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy GENZYME CORPORATION (US) 2009-06-23 US disclosed